Literature DB >> 2860139

Compliance issues in outpatient treatment.

J M Kane.   

Abstract

Estimated compliance rates of 40 to 50% are common among psychiatric outpatients. Likely noncompliers in the acute phase of illness include manic patients, paranoid schizophrenics, and the profoundly depressed. Noncompliance during the long-term prophylactic or maintenance treatment phase tends to increase with the passage of time. The cause of noncompliance is multifactorial. The use of long acting parenteral neuroleptic agents may help decrease the incidence of noncompliance, although documentation is difficult to obtain. Because of the risk of tardive dyskinesia, the lowest possible dose of the depot medication should be used. Studies are now under way to ascertain minimal effective doses necessary to prevent relapse and minimize adverse effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860139     DOI: 10.1097/00004714-198506001-00005

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  10 in total

Review 1.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

2.  Management of schizophrenia : an update.

Authors:  P Kulhara
Journal:  Indian J Psychiatry       Date:  1998-04       Impact factor: 1.759

3.  Medication Adherence Among Adolescents with Bipolar Disorder.

Authors:  Tina R Goldstein; Megan Krantz; John Merranko; Matthew Garcia; Loren Sobel; Carlos Rodriguez; Antoine Douaihy; David Axelson; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-07-15       Impact factor: 2.576

4.  Racial Disparities in Stroke Recovery Persistence in the Post-Acute Stroke Recovery Phase: Evidence from the Health and Retirement Study.

Authors:  Joy N J Buie; Yujing Zhao; Suzanne Burns; Gayenell Magwood; Robert Adams; Catrina Sims-Robinson; Daniel T Lackland
Journal:  Ethn Dis       Date:  2020-04-23       Impact factor: 1.847

5.  Medication compliance among the seriously mentally ill in a public mental health system.

Authors:  C Nageotte; G Sullivan; N Duan; P L Camp
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-02       Impact factor: 4.328

6.  Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms.

Authors:  Robert McCutcheon; Katherine Beck; Michael A P Bloomfield; Tiago R Marques; Maria Rogdaki; Oliver D Howes
Journal:  J Psychopharmacol       Date:  2015-03-18       Impact factor: 4.153

Review 7.  Adherence to medication in the community: audit cycle of interventions to improve the assessment of adherence.

Authors:  Saeed Farooq; Abid Choudry
Journal:  BJPsych Bull       Date:  2017-02

8.  Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study.

Authors:  Dulcinea Vega; Francisco J Acosta; Pedro Saavedra
Journal:  World J Psychiatry       Date:  2020-11-19

9.  Patients' health literacy in psychotic disorders.

Authors:  Ghassen Saba; Lila Mékaoui; Marion Leboyer; Franck Schürhoff
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

10.  Evaluation of treatment adherence in outpatients with schizophrenia.

Authors:  Bhushan Chaudhari; Daniel Saldanha; Adnan Kadiani; Roma Shahani
Journal:  Ind Psychiatry J       Date:  2017 Jul-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.